Slightly elevated B‐type natriuretic peptide levels in a non‐heart failure range indicate a worse left ventricular diastolic function in individuals with, as compared with individuals without, type 2 diabetes: the Hoorn Study

Higher plasma B‐type natriuretic peptide (BNP) in a non‐heart failure (HF) range predicts HF and cardiovascular disease (CVD) mortality in the general population. Heart failure is highly prevalent in type 2 diabetes mellitus (T2DM), but associations of BNP to left ventricular (LV) mass and function in individuals with a different glucose status have not been compared. We therefore aimed to explore (i) the association of BNP levels in a non‐HF range with structural and functional markers of LV function, and (ii) possible effect modification by glucose tolerance categories.

[1]  R. Sacco,et al.  Effect of diabetes and hypertension on left ventricular diastolic function in a high‐risk population without evidence of heart disease , 2010, European Journal of Heart Failure.

[2]  H. Crijns,et al.  Letter by van Kimmenade et al regarding article, "urinary N-terminal prohormone brain natriuretic peptide excretion in patients with chronic heart failure". , 2010, Circulation.

[3]  J Michael Gaziano,et al.  Relation between modifiable lifestyle factors and lifetime risk of heart failure. , 2009, JAMA.

[4]  G. Navis,et al.  Urinary N-Terminal Prohormone Brain Natriuretic Peptide Excretion in Patients With Chronic Heart Failure , 2009, Circulation.

[5]  F. McAlister,et al.  The risk of heart failure in patients with type 2 diabetes treated with oral agent monotherapy , 2008, European journal of heart failure.

[6]  J. Bronzwaer,et al.  Diastolic Stiffness of the Failing Diabetic Heart: Importance of Fibrosis, Advanced Glycation End Products, and Myocyte Resting Tension , 2008, Circulation.

[7]  J. Gottdiener,et al.  Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study. , 2008, European heart journal.

[8]  M. Severo,et al.  Long-term stability of endogenous B-type natriuretic peptide after storage at –20°C or –80°C , 2008, Clinical chemistry and laboratory medicine.

[9]  A. Maisel,et al.  State-of-the-Art PaperNatriuretic Peptides , 2007 .

[10]  Tom Greene,et al.  Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. , 2007, Clinical chemistry.

[11]  D. Kass,et al.  Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction. , 2007, Journal of the American College of Cardiology.

[12]  J. Rehfeld,et al.  Plasma pro-B-type natriuretic peptide in the general population: screening for left ventricular hypertrophy and systolic dysfunction. , 2006, European heart journal.

[13]  Peter C Austin,et al.  Outcome of heart failure with preserved ejection fraction in a population-based study. , 2006, The New England journal of medicine.

[14]  Wolfgang A Linke,et al.  Myocardial Structure and Function Differ in Systolic and Diastolic Heart Failure , 2006, Circulation.

[15]  G. Lip,et al.  Comparison of brain natriuretic peptide and left ventricular diastolic function determined by tissue Doppler in patients with diabetes mellitus, patients with hypertension without diabetes, and in healthy subjects. , 2005, The American journal of cardiology.

[16]  Douglas W Mahoney,et al.  Diastolic dysfunction and left atrial volume: a population-based study. , 2005, Journal of the American College of Cardiology.

[17]  S. Mudaliar,et al.  Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus. , 2004, Journal of the American College of Cardiology.

[18]  L. Groop,et al.  Elevated plasma levels of Nt-proBNP in patients with type 2 diabetes without overt cardiovascular disease. , 2004, Diabetes care.

[19]  L. Sleeper,et al.  Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. , 2004, Journal of the American College of Cardiology.

[20]  Daniel Levy,et al.  Plasma natriuretic peptide levels and the risk of cardiovascular events and death. , 2004, The New England journal of medicine.

[21]  D. Levy,et al.  Impact of Obesity on Plasma Natriuretic Peptide Levels , 2004, Circulation.

[22]  L. Bouter,et al.  Left ventricular mass increases with deteriorating glucose tolerance, especially in women: independence of increased arterial stiffness or decreased flow-mediated dilation: the Hoorn study. , 2004, Diabetes care.

[23]  S. Mudaliar,et al.  Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes. , 2003, Diabetes care.

[24]  Richard Kamin,et al.  Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. , 2003, Journal of the American College of Cardiology.

[25]  N. Westerhof,et al.  Arterial Stiffness Increases With Deteriorating Glucose Tolerance Status: The Hoorn Study , 2003, Circulation.

[26]  Pedro Lozano.  Natriuretic peptides. , 2020, The Journal of the Arkansas Medical Society.

[27]  D. Levy,et al.  Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. , 2002, JAMA.

[28]  M. Drazner,et al.  Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. , 2001, Journal of the American College of Cardiology.

[29]  F. Boomsma,et al.  Relationship between natriuretic peptide concentrations in plasma and posture during blood sampling. , 2001, Clinical chemistry.

[30]  C L Feldman,et al.  Assessment of Left Ventricular Ejection Fraction and Volumes by Real-time, Two-dimensional Echocardiography: A Comparison of Cineangiographic and Radionuclide Techniques , 1979, Circulation.

[31]  Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia Report of a Who/idf Consultation Who Library Cataloguing-in-publication Data , 2022 .